BoneKEy Knowledge Environment March 2012
- Multiple myeloma bone disease: targeting osteoclasts and osteoblasts
- Importance of reversible remodeling suppression with denosumab
- 11th International Conference on Cancer-Induced Bone Disease
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License.